ABSTRACT
INTRODUCTION
Paediatric epilepsy surgery has become increasingly important due to the potential benefits of earlier surgery to optimise seizure and cognitive outcome 1 . In this patient group noninvasive techniques able to localize the epileptogenic zone (EZ) with good sensitivity and specificity are particularly desirable, specifically in patients without an MRI visible lesion. EEG-fMRI and ESI are both good candidates but definitive studies are needed to determine their diagnostic performance in the paediatric population.
Previous EEG-fMRI studies in adults have shown that fMRI can map the epileptogenic zone using interictal 2, 3 and ictal 4 events. Compared to clinical EEG alone, EEG-fMRI has been
shown to provide a more accurate localisation of the epileptogenic zone (EZ) in up to 2/3 of the cases 5 ,to have a good degree of correlation with invasive EEG findings 6 , and to be predictive of good surgical outcome 7, 8 . However, EEG-fMRI maps often show multiple regions of activity which, while being consistent with the idea that epilepsy is a network disease 9, 10 6, 11, 12 , complicates interpretation where a single spatial target is typically required for surgery to proceed. Previous studies have often used the statistic global maxima (GM) 8, 13 , or have constrained the search area to the spike field 5 or to the clinically defined epileptic focus 2, 3 to obtain a localisation. Unfortunately, these approaches can have low sensitivity (in the case of GM) or are dependent on subjective interpretation if using a clinically defined focus or are based on the interictal epileptiform discharges (IED) field. Furthermore, in a paediatric cohort clinical EEG is often less localizing, repeat surgery relatively common and therefore the use of IED fields maybe problematic. Recently EEGfMRI was shown to be feasible in children from 6-18 years old without sedation and possibly have a higher yield compared with adults in a selected population 14 . Additionally, new methodological developments (topographic voltage correlation analysis) 15 allow EEG-fMRI maps to be obtained without IEDs.
ESI has been shown to localize the EZ with high sensitivity and specificity in a mixed group of adults and children using high density (>32 channel) EEG 16 and shown promise in a paediatric cohort 17 . ESI can have limitations in cases of deep sources 18 , previous surgery 19 or where IEDs are not typical discrete events and it has a limited spatial accuracy. Studies have investigated the spatial consistency of EEG-fMRI and ESI maps 20, 21 and their localisation performance 22 but they have not been combined to improve their potential predictive value.
Here, high-density EEG-fMRI data was used to derive ESI and EEG-fMRI maps. We aimed to: a) quantify the yield; b) determine the localizing value; and c) asses the predictive value of EEG-fMRI and ESI individually and as combined test in the largest paediatric focal epilepsy population studied to date with either method.
METHODS Subjects
Fifty-three children with drug-resistant epilepsy underwent simultaneous EEG-fMRI. At the point of recruitment, the children were undergoing evaluation for resective epilepsy surgery at Great Ormond Street Hospital for Children (London, UK). The patients were recruited prospectively between November 2011 and May 2015; inclusion criteria for the study were the presence of frequent interictal discharges and the capacity to undergo an unsedated MRI.
The clinical data of the 53 patients are summarized in supplementary Table 1 . Thirty patients had a structural lesion on MRI (56%) and twenty-three (44%) were lesion negative.
a) Patient group for yield assessment
All 53 patients were included in the calculation of test yield.
b) Patient group for localisation value assessment
All patients underwent videotelemetry-EEG to document seizures and structural MRI for pre-surgical assessment. In 29/53 patients the EZ was considered well-localised based on the following criteria: 1) MRI lesion concordant with the electro-clinical data (15 patients) or 2) good outcome following surgery (14 patients; 12 lesional/2 non-lesional). Patients with a poor outcome or without an MRI lesion (unless they had a good surgical outcome) were excluded from this group because their EZ was not well localised. The volume of the EZ was estimated and these values are included in supplementary Table 1 .
c) Patient group for prediction of surgical outcome assessment
All 20 patients within the study who underwent resective surgery were included. Five out of 20 had normal MRI. Surgical outcome for each patient was classified according to the modified ILAE classification system 23 before being further divided into good or poor outcome based on the surgical goal being met. Good outcomes were therefore considered to be ILAE class 1 and 2. In 3 patients with large lesions (involving more than one lobe) a partial resection of the lesion was chosen in order to spare eloquent cortex. In these patients if a significant seizure reduction of >50% was achieved (ILAE class 4) the outcome was considered to be a favourable as this was the a priori surgical aim. For all other categories outcome was considered to be poor. The relative brain volume that was resected was estimated and these values are included in supplementary Table 1 .
EEG-fMRI acquisition
Full scanning protocol details are described in our previous work 14 . Patients were prepared with a 64-electrodes MRI compatible EEG cap (Easy cap, Brain Products, Munich, Germany). All patients underwent between 2 to 4 EEG-fMRI sessions lasting 10 minutes each (300 volumes TR 2.16s) and a T1-weighted whole-brain structural image. In order to keep consistency across subjects only the first two sessions (20 minutes) of EEG-fMRI were used in the analysis with the added benefit of reduced subject movement without affecting BOLD results 14 . In 2 patients in whom seizures with movement occurred during the first 2 sessions the subsequent sessions free of seizures were analysed.
Pre-processing of EEG and identification/classification of interictal epileptiform discharges (IED) on EEG traces were carried out as described previously in Centeno et al. 14 . In summary, IED for each subject were classified as a separate IED type according to the topographical distribution of the activity 13 .
EEG-fMRI analysis

IED-correlation analysis
A mass univariate fMRI analysis was performed using SPM8 version r5232 (http://www.spm.fil.ion.ucl.ac.uk) running in matlab (Mathworks, Natick, USA).
Pre-processing consisted of image realignment (SPM8) followed by the removal of nonphysiological signal changes using FIACH 24 . Slice time correction and smoothing with an 8mm kernel was subsequently applied (SPM8).
A general linear model was generated for each subject where for each IED type, IED onset (and duration in the case of IED runs) was convolved with the canonical HRF and its time and dispersion derivatives. Motion realignment parameters and FIACH physiological noise regressors 14, 24 were entered as effects of no interest. Brain regions with signal changes associated with each IED type were tested with an F-test across the three IED regressors (HRF and the two derivatives) to account for variability in the haemodynamic response shape 25, 26 . A more detailed explanation of the model used can be found in Centeno et al. 14 .
Topographic IED voltage map correlation
In those patients in whom IED were not captured during the EEG-fMRI sessions, a regression analysis of the typical IED topographic voltage maps was applied to the EEG-fMRI data following the procedure described by Grouiller et al 15 . In brief, a patient's IED topography derived from their clinical EEG is spatially correlated with the topography of the EEG obtained inside the scanner at each time point. The fMRI signal changes associated with an increased correlation to the IED topography are obtained, which can reflect the generators of focal epileptic activity 27, 28 .
Changes in Blood Oxygenation Level Dependant (BOLD) fMRI signal were considered significant at an individual level above a threshold of p<0.001 (uncorrected) and a cluster size voxel with a minimum of 5 contiguous voxels 14 . This threshold is arbitrary but was chosen apriori to strike an appropriate balance between sensitivity and specificity based on the range of design efficiency that is encountered between patients. This threshold was applied to both IED-related and topographic correlation analysis maps.
Electrical source imaging
Only patients with IEDs captured during the EEG-fMRI sessions (using a 64 electrode cap) had electrical source imaging (ESI). We calculated the ESI of each IED type identified on the EEG using Cartool software (https://sites.google.com/site/fbmlab/cartool) and followed the procedure described in Vulliemoz et al. 29 .
Localisation derived from EEG-fMRI and ESI individually and combined
A single localisation was derived from each EEG-fMRI and ESI map used individually and then subsequently a combined localisation was derived (Fig 1) .
Individual test localisation
The single localisation obtained from EEG-fMRI maps was the cluster containing the statistical global maximum. The single localisation from the ESI maps was the ESI maxima solution point for the map corresponding to the 50% rising phase of the IED.
Combined EEG-fMRI/ESI localisation
To obtain a single localisation from the combination of EEG-fMRI and ESI, both maps were coregistered and overlaid on the subject's structural T1-wighted image. Combined EEGfMRI/ESI localisation was extracted in those cases in whom ESI maxima and an EEG-fMRI cluster were localised to the same sublobar region. Sublobar regions were defined as follows 30 : frontal polar, dorsal lateral frontal, mesial frontal, lateral parietal, mesial parietal, lateral occipital, mesial occipital, lateral temporal, temporal polar, and mesial temporal. The location derived from the combined EEG-fMRI and ESI maps was defined as the region that comprised both the ESI maxima and the nearest EEG-fMRI cluster within the same sublobe. Additionally, the Euclidian distance between the ESI maxima and EEG-fMRI cluster located in the same sublobe was calculated for the combined EEG-fMRI/ESI cases.
Assessment of the value of the EEG-fMRI and ESI
a) Test yield
To determine the ability of the test to provide a localisation result the 'test yield' was calculated and is given by the number of patients with a test localisation result/total number that received the test.
b) Localisation accuracy
Here, we aimed to address the question 'given a test localisation result, what is the probability that it is correct?'. To do this, the patient group with a well localised EZ (n=29 see above) was used (Fig 2) . When the test resulted in a localisation and it fell within the EZ it was classed as a true positive (a correct localisation); otherwise if the test resulted in a localisation and it did not fall within the EZ it was considered a false positive (an incorrect localisation). This was repeated for the individual localisation results from ESI and EEG-fMRI and for the combined localisation. Note that where the test does not provide a localisation, the test cannot be categorised as providing true or false, positive or negative localisation information (the absence of evidence cannot be taken as evidence of absence).
c) Surgery outcome prediction
Thirdly we aimed to assess the ability of EEG-fMRI and ESI localisation to predict seizure outcome (Fig 2) . In patients who underwent surgery, we defined a true positive as being when the localisation provided by the test was resected with a good outcome; false positive as when the localisation provided by the test was resected followed by a poor outcome. True and false negatives were defined as the localisation provided by the test not being resected and the outcome being poor and good respectively 8 . True positives and true negatives were considered correct predictions (prediction successes), otherwise the prediction was incorrect (prediction failures).
Statistical analysis and confidence estimates
Binomial calculations are often used to quantify uncertainty in diagnostic test sensitivities using confidence intervals. However, these intervals are inaccurate if percentages approach 100%. We therefore adopted a Bayesian approach to estimating the sensitivity and the associated uncertainty. The prior information we incorporate is in the form of a Beta distribution which is the typical prior for proportions 31 . The Beta distribution has two parameters: α and β which both have a meaningful clinical interpretation. For EZ localisation, the parameter α is simply the number of times a given test correctly localised the EZ. Whereas the β parameter is the number of times the test incorrectly localised the EZ. For surgical prediction α is the number of successful predictions (true positives plus true negatives) whereas β is the number of failures (false positives plus false negatives).
The values for α and β for the prior distribution can incorporate information from previous studies. When none is available the starting assumption is that α and β are equally likely and so α=β=1 (in this special case the prior is a uniform distribution also called a flat prior). For EEG-fMRI-GM we incorporated information from two studies 8, 13 . The resulting prior for EEG-FMRI-GM sensitivity(ߐ) was ߐ~ߚ݁‫ܽݐ‬ሺ14,10ሻ. For ESI we used the study by Brodbeck et al 16 . The resulting prior for ESI is ߐ~ߚ݁‫ܽݐ‬ሺ45,9ሻ. In the absence of data for the combined method the prior remained uninformative (ߐ~ߚ݁‫ܽݐ‬ሺ1,1ሻ).This prior remained the same for the localisation sensitivity and the prediction of surgical outcome. These priors were then used together with our data to describe the posterior distribution of sensitivity in the population. The uncertainty was then simply characterised using a 95% credible interval calculated using the 0.975 and 0.025 quantiles of the posterior distribution.
The chance level of localisation was based on the estimated EZ volume or resection volume (see supplementary Table 1 ). The distribution of this variable was unknown a priori. In order to calculate the mean chance level of localisation and associated measures of uncertainty we therefore used a bootstrap procedure. This was implemented in the boot package of the R Programming language 32, 33 . The number of bootstrap replicates was 5000. Credible intervals were calculated using the 0.975 and 0.025 quantiles of the resulting distribution of the mean. The sensitivity of a given test lies within the credible interval with 95% probability and is therefore considered here to be significantly improved (relative to chance levels or other tests) when the 95% intervals did not overlap.
RESULTS
Forty-four out of 53 patients (83%) had IED during EEG-fMRI sessions. The number of IED types per patient ranged from 1 to 4 (mean 1.6). Twenty-four patients (54%) had 1 IED type; fourteen patients (31%) had 2 types of IED, five patients (11%) had 3 types of IED and one patient (2%) had 4 types of IED (supplementary Table 2 ). The results are summarised in Table 1 .
a) Test Yield
In summary, 52/53 patients (98%) had a significant result for at least one of the tests.
Forty-seven/53 patients had significant clusters of activity on the EEG-fMRI maps (88% test yield). Thirty-nine of the EEG-fMRI maps were IED-related and eight were topographicvoltage-correlation maps (8/9 patients without IEDs). The EEG-fMRI maps contained more than one cluster in 46 out of 47 patients.
ESI was obtained in 39/53 patients (73% test yield). In fourteen patients ESI could not be obtained due to the following reasons: no IED (nine patients); IED rhythmic irregular bursts (one patient), EEG artefact (one patient), structural MRI pre-processing problems (three patients).
The combined ESI/EEG-fMRI gave a single localisation in 23/53 patients (43% test yield). In 11/23 patients, the EEG-fMRI cluster that was concordant with ESI was the global maxima. The mean distance between EEG-fMRI and ESI maxima was 14.6 mm ranging from 5 to 30 mm in the combined EEG-fMRI/ESI. A summary of test yield for MRI negative and lesional patients is shown in Figure 3 . Details of individual subject's localisation derived from EEGfMRI/ESI used individually and combined can be found in supplementary Table2.
b) Localisation accuracy
Twenty-six out of the 29 patients with a well characterized EZ had significant BOLD changes on EEG-fMRI maps; 11/26 correctly localised the EZ with the GM. Twenty-two patients out of the 29 had an ESI map; in 17/22 the maxima correctly localised the EZ. Twelve out of the 29 had a combined localisation from EEG-fMRI and ESI maps; 11/12 correctly localised the EZ (Table 1 ). The localisation performance of all tests was above chance levels. Both ESI and the combined test were better at localising than the EEG-fMRI GM method based on the criteria of non-overlapping 95% intervals (see table 1 ).
c) Surgical prediction accuracy
Twenty patients underwent surgery and had post-operative outcome (mean 29 months, range 10 to 57 months). Eleven patients (55%) were seizure free. Nine patients continued having seizures after surgery and were classified as ILAE class 2 (1 patient), class 4 (3 patients) and class 5 (5 patients) (see supplementary Table 1 ). Two of the patients underwent a partial resection of a large lesion with the aim of significantly reducing the seizure burden but not necessarily seizure freedom. These patients (#28 and #39) had an outcome ILAE 4, with a reduction >of 50% and so were additionally considered as having a good outcome based on the different aim of the surgery. Therefore, the total number of patients with good outcome was 14/20. Five patients in the surgical group were MRI negative (#2,#7,#25,#44,#50). Four of these had both EEG-fMRI and ESI maps with three of them having a combined EEG-fMRI/ESI localisation (#25,#44,#50).
Outcome was correctly predicted in 8/20 patients by the EEG-fMRI GM, in 13/16 by ESI and in 9/9 by combined EEG-fMRI and ESI. The predictive performance of all tests was above chance level, and both ESI and the combined test were better at localising than the EEGfMRI GM methods based on the criteria of non-overlapping 95% intervals (see table 1)
DISCUSSION
In this study, we retrospectively evaluated the potential localising and predictive value of EEG-fMRI and ESI individually and when used as a combined test in the largest paediatric focal epilepsy population studied to date with either method.
The yield of EEG-fMRI alone was 89%, ESI alone 73% and combined EEG-fMRI/ESI 43%. Low yield has been highlighted as a limiting factor for the clinical use of EEG-fMRI. Studies report significant findings in 27% to 76% of the cases 2, 5, 13 . The improvement in the yield in our study may be explained by the population of paediatric patients studied whom typically have frequent IED and the use of topographic correlation analysis (which allowed a localisation to be achieved in the cases without IEDs).
All tests were more accurate than chance levels of correct localisation (Table 1) . Both combined ESI/EEG-fMRI (92%) and ESI (82%) were more accurate than the EEG-fMRI GM localisation (50%). The results for surgical outcome prediction were consistent with the localisation results. All tests were significantly more predictive than chance levels. Both combined ESI/EEG-fMRI (91%) and ESI (83%) were more accurate than the EEG-fMRI GM localisation (50%). Importantly this surgical group of 20 included 5 patients without an MRI lesion. ESI obtained a localisation in 4/5 and in all patients it was predictive of outcome.
Combined EEG-fMRI/ESI obtained a localisation in 3/5 and in all patients it was predictive of outcome.
Comparison with previous studies
Previous studies have shown the potential of EEG-fMRI maps to localize and contribute to the EZ characterization 2, 5, 8, 13 . However, the localisation accuracy of EEG-fMRI remains poorly characterized in the literature. EEG-fMRI maps often show a multifocal pattern of significant responses and this has led to different ways of extracting a single localisation from an EEG-fMRI map. The statistic global maximum has often been used as the marker of the cluster likely to represent the EZ 5, 8 . Although the GM is an unbiased and easy method to extract a single location from a multifocal EEG-fMRI map it suffers from poor sensitivity because it is often located in regions remote from EZ. In a recent study 8 the EEG-fMRI GM was shown to have a sensitivity of 45% to localize the EZ which is in line with our findings.
The meaning and clinical significance of the often multi-focal EEG-fMRI maps of interictal epileptiform activity remains unclear, a fact closely related to the problem of defining the test's localisation result. In this study, we proposed an alternative and unbiased method to extract a single location from EEG-fMRI data by incorporating the IED information through ESI maps and assessing the concordance between them. This method relies exclusively on imaging information, avoiding the interpretation bias of viewing EEG-fMRI and ESI maps in light of clinical information. However, despite being very accurate, the yield of combined ESI and EEG-fMRI was modest (23/53) compare to EEG-fMRI (47/53) in our patient group. Given the high yield but low accuracy of the EEG-fMRI GM to define the EZ, the clinical utility of EEG-fMRI could potentially be dramatically improved by epileptic network characterisation methods that can define the EZ and regions of propagation directly from EEG-fMRI data 29 . Studies focused on comparing these results with the epileptiform activity measured invasively, including with simultaneously acquired fMRI 34, 35 , may help resolve this issue.
EEG-fMRI clusters of activity and ESI maps have been shown to have both a good spatial consistency with the icEEG findings but they do not completely overlap 20 . Bagshaw et al 36 reported a mean distance of ~60 mm between the ESI and EEG-fMRI activity clusters obtained in separate sessions. In our data we found an average distance of 14 mm with a range (5 to 30) in the cases where a concordant localisation was found with EEG-fMRI and ESI. These distances and the concordance between ESI and EEG-fMRI GM are consistent with a previous study in adults 29 . This difference could suggest that each technique is more sensitive to different regions involved in the IED and may contribute to a better characterization of EZ than each map alone. However, EEG source localisation is typically considered to have a spatial accuracy of order ~1cm and there are likely to be differences in the location of the maxima of regional electrical and hemodynamic responses the latter being sensitive to the local vascular architecture. These methodological considerations could easily account for the average difference in localisation of 14mm found here. There are a number of methodological choices that could influence the accuracy of the ESI results. A greater EEG density (above the 64 channels used here) may improve the spatial accuracy of ESI 37, 38 . We used a Spherical Head Model with Anatomical Constraints (SMAC) based on a 3-shell spherical realistic head model and the patient's individual MRI spherical head model, this is an active area of research and more advanced and specific models may also improve accuracy 38 . These methodological choices were motivated by our desire to make a comparison to the largest study of the application of ESI to presurgical epilepsy evaluation in the literature 37 and so we therefore followed the same approach.
ESI was shown to accurately map the generators of IED from data obtained during an EEGfMRI recording in our paediatric population, providing useful predictive information for the presurgical assessment. The sensitivity of ESI alone to localise the EZ was 82% which replicates the results in a previous study, which examined a mixed cohort of adults and children using EEG data from outside the scanner 16 . ESI is therefore a technique that can provide a relatively low cost minimally invasive test with high accuracy in the context of evaluation for paediatric epilepsy surgery. However, its accuracy may be more limited in some cases such as those with deep sources, or in patients with brain and skull abnormalities. In our sample, there were 6 cases in whom ESI was inconsistent with the MRI lesion. Four of them were patients with deep lesions and one patient had undergone previous surgery.
To determine test sensitivity and their reliability we used a Bayesian approach. This allowed the incorporation of prior information (where available) to increase the confidence in our results. For ESI and EEG-fMRI-GM the priors on the sensitivity were very consistent with the data from the current study and therefore their incorporation had little effect on the sensitivity but reduced the credible interval (crucially allowing for more accurate population level inference). For the combined EEG-fMRI/ESI the uninformative prior reduces the sensitivity estimate (reflecting our uncertainty in this novel methodology due to low numbers). Using this approach, future studies can readily update these numbers to further refine these sensitivity estimates by using our posterior distributions as priors in their work.
Clinical value
The aim of presurgical evaluation is to identify a clear hypothesis for the EZ that can be confirmed by intracranial recording or allows for surgery to be offered with an appropriate understanding of risk-benefit. In patients that have an MRI lesion consistent with electroclinical information this is often achieved. However, for patients without an MRI lesion it becomes difficult to formulate a spatially constrained hypothesis. PET and SPECT can be used to formulate a spatial hypothesis 39 , however the spatial accuracy of these techniques is poor. In this study, we have shown that a combined EEG-fMRI & ESI result from a single data set is highly localizing and predictive of surgical outcome with or without an MRI lesion. Furthermore, the localisation provided by these tests (typically at the sublobar level) is more spatially accurate than most of the current non-invasive presurgical test (EEG, PET & SPECT) which are used to localize the EZ in patients with no MRI lesion.
Limitations
This study is limited by the numbers in the subgroup of patients in whom the validation of the localisation results could be carried out (29/53 ). This represents a potential (but unavoidable) bias, because the patients in whom an EZ is well characterised may not fully represent the sample. We included a group of 23 MR negative patients that have a poorer likelihood of having a well-defined EZ, and therefore surgical outcome data. This choice was necessitated by the need for an assessment of the localisation tests accuracy in this group. A combined EEG-fMRI/ESI localisation was found in 12/23 MRI negative patients and outcome was predicted in all 3 whom had surgery. Our results therefore strongly motivate a larger study of combined EEG-fMRI and ESI in MRI negative patients with validation based on intracranial EEG or surgery.
Patients with a well-defined cortical MRI abnormality concordant with electro-clinical information are unlikely to benefit from EEG-fMRI given its cost. In these cases, based on our data, ESI represents an additional relatively low-cost test with a good sensitivity in children with frequent IEDs. However, patients without an MRI visible abnormality, a deep lying or extensive MRI abnormality, and/or prior surgery are likely to benefit from combined EEG-fMRI and ESI. 
FIGURE LEGENDS Figure 1: Localisation extraction procedure
From left to right; EEG-fMRI data is used to obtain a map for EEG-fMRI and ESI. For each of these individual maps a single localisation is selected: for the EEG-fMRI the global maxima is selected and for the ESI the maxima in the map from the 50% rising phase of the IED is selected. For the combined test the localisation is derived from the spatial conjunction of both maps. Where the maps are concordant the localisation is the region encompassing the ESI max and the closest significant EEG-fMRI cluster located in same sublobe. When the maps are discordant cases no combined localisation is extracted.
Figure 2: Validation of individual and combined EEG-fMRI and ESI maps
The localisations derived from the single and combined test were validated by: 1) Calculating localisation accuracy in those patients with a well characterized EZ. For each localisation method its accuracy was classified as a true positive (TP) if it was located in the presumed EZ (top row) or False positive (FP) if it was not;
2) Calculating the prediction accuracy for seizure outcome in all patients who underwent surgery (bottom row). Here a true positive (TP) was a localisation within the resection margins and good outcome; a false negative (FN) was a localisation within the resection margins and poor outcome; true (TN) and false negatives (FN) were a localisation that was not within the resection margins and a poor or good outcome respectively.
Figure 3: Summary flowchart
The number of significant results for each of the test individually and in combination is summarised in for the MRI negative and MRI lesion patients respectively. The diagram shows the number patients with a combined EEG-fMRI/ESI result that were validated by surgical outcome for MRI lesion and MRI negative patients. Test yield is calculated as the number of subjects in whom a significant map was obtained.
Localisation accuracy was calculated in those patients with well localized epileptogenic zone (EZ), and surgical prediction in those patients who underwent surgical resection. n is the number of subjects where the test provided a result. The current study summary row gives the number of true positives (TP), false positives (FP), true negatives (TN) and false negatives (FN) . The test sensitivity is, given a result, the likelihood it was correct; α and β are the hyperparameters of the beta distribution. Prior hyperparameters are based on the results of previous studies where available or are set to both equal 1 where there is no prior information.
Supplementary Table1: Clinical data.
Presumed epileptogenic zone (EZ) is the region where the EZ was located after non-invasive test. In those patients with well characterized EZ (presence of MRI lesion or good surgical outcome) the relative volume of EZ was estimated by the following process. When the resected cavity or MRI lesion was defined as being at a hemisphere level a volume of 0.5 was assigned, lobar level lesions or resections were assigned a relative brain volume of 0.1 for occipital, temporal and parietal lobes and 0.2 for the frontal lobe. For sublobar lesions or resections the volume was estimated by expert visual assignment of the AAL atlas regions involved (M.C.). The relative volume was then calculated as a sum of AAL regions relative volume. One patient had a hypothalamic haematoma and therefore a relative volume of 0.03 was used. Note that this approach was used to provide a maximum bound on the EZ volume and therefore a conservative statistical assessment of localisation probabilities. 
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